Avi Biopharma Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Avi Biopharma Inc
TickerSRPT
CIK #0000873303
CUSIP803607100
SectorLife Sciences - Pharmaceutical Preparations
Address3450 Monte Villa Parkway Suite 101, Bothell, WA 98021
Source [EDGAR]
CIK Filing 2011 - 2025
[0000873303] 10-K
[0000873303] 10-Q
[0000873303] 3
[0000873303] 4
[0000873303] 5
[0000873303] 8-K
[0000873303] D
[0000873303] SC 13D
[0000873303] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
D E Shaw & Co LP Sarepta Therapeutics Inc [2025-07-25] 0.0
Sarepta Therapeutics Inc Arrowhead Pharmaceuticals Inc [2025-02-14] 0.0
Capital International Investors Sarepta Therapeutics Inc [2024-02-09] 5.1
Sands Capital Management LLC Sarepta Therapeutics Inc [2022-02-14] 6.16
Janus Henderson Group PLC Sarepta Therapeutics Inc [2022-02-11] 8.3
Sands Capital Management LLC Sarepta Therapeutics Inc [2021-02-16] 1.24
Capital Research Global Investors Sarepta Therapeutics Inc [2021-02-10] 0.8
Sands Capital Management LLC Sarepta Therapeutics Inc [2020-02-14] 6.1
Price T Rowe Associates Inc /MD/ Sarepta Therapeutics Inc [2019-02-14] 6.1
FMR LLC Sarepta Therapeutics Inc [2018-02-09] 0.0
Capital Ventures International Sarepta Therapeutics Inc [2017-12-21] 5.4
Point72 Asset Management LP Sarepta Therapeutics Inc [2017-02-23] 5.2
Tourbillon Capital Partners LP Sarepta Therapeutics Inc [2016-10-28] 6.2
Sabby Management LLC Sarepta Therapeutics Inc [2016-05-06] 5.15
FMR LLC Sarepta Therapeutics Inc [2016-02-12] 0.0
Barry Richard Sarepta Therapeutics Inc [2015-05-05] 7.66
Point72 Asset Management LP Sarepta Therapeutics Inc [2015-05-01] 5.3
Point72 Asset Management LP Sarepta Therapeutics Inc [2014-04-30] 5.2
Perceptive Advisors LLC Sarepta Therapeutics Inc [2014-02-14] 0.45
Susquehanna Capital Group Sarepta Therapeutics Inc [2014-02-13] 5.2
Vanguard Group Inc Sarepta Therapeutics Inc [2014-02-11] 5.48
Columbia Wanger Asset Management LLC Sarepta Therapeutics Inc [2014-02-06] 7.0
BlackRock Inc Sarepta Therapeutics Inc [2014-01-30] 6.7
Sabby Management LLC Sarepta Therapeutics Inc [2013-04-24] 5.26
[2012-11-19] None
Form 3/4/5 Filer 2011 - 2025
Sarepta Therapeutics, Inc.
Arif Bilal
Rodino-Klapac Louise
Estepan Ian Michael
Wong Ryan Ho-Yan
Barry Richard
Nicaise Claude
Chambers Michael Andrew
Rothfuss Cristin
Mayo Stephen
Behrens M Kathleen
Boor Kathryn Jean
Connelly Deirdre P
Wigzell Hans Lennart Rudolf
Murray Dallan
Brown Ryan Edward
Ingram Douglas S
Ciambrone William
Gray Mary Ann
O'Neill Gilmore Neil
Martin John C
Bratica Joseph
Mahatme Sandesh
Howton David T
Cumbo Alexander
Bonney Michael W
Ruff Shamim
Basi Guriqbal S.
Kaye Edward M. MD
Stehman-Breen Catherine
Kress Jean-Paul
Wood Joan
Aphale Jayant
Price Ben Gil
Goolsbee William Alden
Hodgman John
Christopher Nishan Garabedian
Chase Anthony R
Krieg Arthur M
Martignetti Anthony
Jacobsen Michael A
Form 13F Holdings
Firm Period DFND Voting Shares
BlackRock, Inc. [2025-06-30] SOLE 11,416,108 12,115,044
Vanguard Group Inc [2025-06-30] SOLE 0 9,001,077
State Street Corp [2025-06-30] DFND 4,441,723 4,695,027
D. E. Shaw & Co., Inc. [2025-06-30] DFND 4,506,253 4,565,138
Wellington Management Group LLP [2025-06-30] DFND 0 2,530,455
Susquehanna International Group LLP [2025-06-30] OTR 180,246 2,208,046
Two Sigma Investments LP [2025-06-30] SOLE 2,161,697 2,161,697
Two Sigma Advisers LP [2025-06-30] SOLE 1,916,134 1,985,734
Geode Capital Management LLC [2025-06-30] DFND 1,858,076 1,875,997
Jane Street Group LLC [2025-06-30] DFND 1,128,477 1,633,177
Erste Asset Management GmbH [2025-06-30] SOLE 1,536,000 1,621,415
Qube Research & Technologies Ltd [2025-06-30] SOLE 1,600,372 1,600,372
Morgan Stanley [2025-06-30] DFND 1,253,888 1,486,926
Voloridge Investment Management LLC [2025-06-30] SOLE 1,474,155 1,474,155
Federated Hermes Inc [2025-06-30] DFND 1,308,193 1,308,199
Aberdeen Group plc [2025-06-30] DFND 1,242,404 1,242,404
BNP Paribas Financial Markets [2025-06-30] DFND 0 1,233,049
Caption Management LLC [2025-06-30] SOLE 1,084,600 1,084,600
Millennium Management LLC [2025-06-30] SOLE 1,062,205 1,062,205
Citadel Advisors LLC [2025-06-30] DFND 1,005,556 1,005,556
Casdin Capital LLC [2025-06-30] SOLE 990,097 990,097
Bank of America Corp /DE/ [2025-06-30] DFND 66,376 916,795
Norges Bank [2025-06-30] SOLE 913,407 913,407
Y-Intercept (Hong Kong) Ltd [2025-06-30] SOLE 870,181 870,181
Assenagon Asset Management S.A. [2025-06-30] SOLE 867,939 867,939
Ikarian Capital LLC [2025-06-30] SOLE 781,187 781,187
Dimensional Fund Advisors LP [2025-06-30] SOLE 699,989 749,092
Walleye Capital LLC [2025-06-30] SOLE 738,625 738,625
Balyasny Asset Management LP [2025-06-30] SOLE 734,728 734,728
Whitebox Advisors LLC [2025-06-30] SOLE 714,600 714,600
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com